134 related articles for article (PubMed ID: 11378584)
1. Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus.
Robak T; Robak E; Bartkowiak J; Błoński JZ; Niewiadomska H; Wawrzyniak E
Leuk Lymphoma; 2001 May; 41(5-6):659-67. PubMed ID: 11378584
[TBL] [Abstract][Full Text] [Related]
2. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation.
Offit K; Parsa NZ; Filippa D; Jhanwar SC; Chaganti RS
Blood; 1992 Nov; 80(10):2594-9. PubMed ID: 1384792
[TBL] [Abstract][Full Text] [Related]
3. Concomitant manifestation of systemic lupus erythematosus and low-grade non-Hodgkin's lymphoma.
Munzert G; Frickhofen N; Bauditz J; Schreiber S; Herrmann F
Leukemia; 1997 Aug; 11(8):1324-8. PubMed ID: 9264388
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin's lymphoma in patients with systemic lupus erythematosus.
Papadaki HA; Xylouri I; Katrinakis G; Foudoulakis A; Kritikos HD; Stathopoulos EN; Boumpas DT; Eliopoulos GD
Leuk Lymphoma; 2003 Feb; 44(2):275-9. PubMed ID: 12688345
[TBL] [Abstract][Full Text] [Related]
5. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology.
Schwonzen M; Pohl C; Steinmetz T; Wickramanayake PD; Thiele J; Diehl V
Br J Haematol; 1992 Jul; 81(3):362-9. PubMed ID: 1382545
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
8. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.
Liossis SN; Solomou EE; Dimopoulos MA; Panayiotidis P; Mavrikakis MM; Sfikakis PP
J Investig Med; 2001 Mar; 49(2):157-65. PubMed ID: 11288756
[TBL] [Abstract][Full Text] [Related]
9. Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease.
Escribano L; Orfao A; Villarrubia J; Cerveró C; Velasco JL; Martín F; San Miguel JF; Navarro JL
Br J Haematol; 1995 Dec; 91(4):941-3. PubMed ID: 8547146
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
11. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
12. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis.
Miller ML; Fishleder AJ; Tubbs RR
Am J Clin Pathol; 1991 Jul; 96(1):100-8. PubMed ID: 2069128
[TBL] [Abstract][Full Text] [Related]
13. Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab.
Rossi EA; Goldenberg DM; Michel R; Rossi DL; Wallace DJ; Chang CH
Blood; 2013 Oct; 122(17):3020-9. PubMed ID: 23821660
[TBL] [Abstract][Full Text] [Related]
14. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: recent results and future prospects.
Renner C; Trümper L; Pfreundschuh M
Leukemia; 1997 Apr; 11 Suppl 2():S55-9. PubMed ID: 9178842
[TBL] [Abstract][Full Text] [Related]
16. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
Hurwitz CA; Gore SD; Stone KD; Civin CI
Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.
Echeverri C; Fisher S; King D; Craig FE
Am J Clin Pathol; 2002 Apr; 117(4):615-20. PubMed ID: 11939737
[TBL] [Abstract][Full Text] [Related]
20. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]